DUBLIN--(BUSINESS WIRE)--The "Lutathera - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering.
Lutathera - Drug Insight, 2019 report provides comprehensive information of the drug, Lutathera. It includes drugs overview, Lutathera mechanism of action, clinical trials, regulatory milestones, deals & Lutathera's partnerships. It further provides Lutathera's patents (US & EU) and its API manufacturers details in the United States, Europe, China and India.
It also features the historical and forecasted Lutathera sales till 2021. The report also throws light on Lutathera market competition and emerging therapies in the same space as Lutathera. Lutathera SWOT analysis is also featured.
Scope of the Report
- A comprehensive Lutathera overview including product description, regulatory milestones, clinical trials, deals and partnerships, have been elaborated in this report
- Lutathera Patent information in United States (US) and Europe (EU) has been highlighted
- Lutathera API manufacturers in United States, Europe, China and India
- The report contains historical and forecasted Lutathera sales till 2021
- Comprehensive coverage of the emerging therapies (Phase III) in the space where Lutathera operates including their product description, research and development activities, collaborations and licensing deals, drug mechanism and chemical information
- The report also features the Lutathera SWOT analysis
Reasons to Buy
- Establish a comprehensive understanding of the drug, Lutathera
- Access to Lutathera API manufacturers details to devise API procurement strategy for generic development
- Plan developmental timelines around Lutathera patents for the major markets - US and EU
- Understand current and future Lutathera's growth through its historical and forecasted sales
- Identify and understand the current in-market competitors for Lutathera
- Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
- Identify and plan ahead for prospective emerging players and their products operating in the same space as Lutathera
- Identify opportunities in the same area as with Lutathera SWOT analysis
Key Topics Covered
1. Report Introduction
2. Lutathera - Overview
- Lutathera Product Description
- Lutathera Route of Synthesis
- Lutathera Mechanism of Action
- Lutathera Pharmacology
- Lutathera Pharmacodynamics
- Lutathera Pharmacokinetics
- Lutathera Adverse Reactions
- Lutathera Clinical Trials
- Lutathera Regulatory Milestones
- Lutathera Development Activities
3. Global API Manufacturers
- United States
- Europe
- China
- India
4. Product Details
- United States
- Europe
5. Lutathera Global Sales Assessment
- Lutathera Sales Global(Historical)
- Lutathera Sales Global(Forecasted)
6. Lutathera Patent Details
7. Lutathera Market Competition
8. Lutathera Emerging Therapies
8.1. Drug name: Company name
- Product Description
- Research & Development
- Product Development Activities
9. Lutathera SWOT Analysis
List of Tables
Table 1: Lutathera, Description
Table 2: API Manufacturers Region wise
Table 3: API Manufacturers for United States
Table 4: API Manufacturers for Europe
Table 5: API Manufacturers for China
Table 6: API Manufacturers for India
Table 7: Lutathera Product Details, United States
Table 8: Lutathera Product Details, Europe
Table 9: Lutathera, Historical Global Sales till 2017 (in million USD)
Table 10: Lutathera, Forecasted Global Sales from 2019-2021 (in million USD)
Table 11: Patent Details: Lutathera
Table 12: Lutathera Major Competitors
Table 13: Emerging Therapies
List of Figures
Figure 1: Lutathera
Figure 2: Lutathera, Historical Global Sales till 2017 (in million USD)
Figure 3: Lutathera, Forecasted Global Sales from 2019-2021 (in million USD)
Figure 4: Patent Details: Lutathera
Figure 5: API Manufacturers Region wise
For more information about this report visit https://www.researchandmarkets.com/r/c7sg9l
